Nonadherence to oral linezolid after hospitalization: a retrospective claims analysis of the incidence and consequence of claim reversals.

Link to article at PubMed

Nonadherence to oral linezolid after hospitalization: a retrospective claims analysis of the incidence and consequence of claim reversals.

Clin Ther. 2010 Dec;32(13):2246-55

Authors: Ball AT, Xu Y, Sanchez RJ, Shelbaya A, Deminski MC, Nau DP

Linezolid is available in an oral as well as an intravenous formulation. It is an oxazolidinone antibiotic and is effective in treating resistant gram-positive organisms such as methicillin-resistant Staphylococcus aureus and multidrug-resistant Streptococcus pneumoniae.

PMID: 21316540 [PubMed - indexed for MEDLINE]

Leave a Reply

Your email address will not be published. Required fields are marked *